Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Strategic Alliance Partners

November 16, 2020

Nilofer S. Azad, MD, highlights colorectal cancer treatment and how it has entered an era that is both exciting and challenging.

October 30, 2020

Nilofer S​aba Azad, MD, discusses selecting between regorafenib and TAS-102 in colorectal cancer.

October 29, 2020

Nilofer S​aba Azad, MD, discusses third-line treatment options for patients with colorectal cancer.

October 28, 2020

Benjamin P. Levy, MD, discusses the mechanism ​of action of telaglenastat in non–small cell lung cancer.

October 21, 2020

Nilofer S​aba Azad, MD, discusses future research efforts in colorectal cancer.

October 19, 2020

Nilofer S​aba Azad, MD, discusses the significance of germline testing in colorectal cancer.

October 16, 2020

Nilofer S​aba Azad, MD, discusses treatment considerations in right- versus left-sided colorectal cancer.

September 14, 2020

Jerry L​e Pow Spivak, MD, discusses the prevalence of polycythemia vera.  

September 09, 2020

Kala Visvanathan, MD, MBBS, MHS, discusses the rationale for ​evaluating lipophilic statins in epithelial ovarian cancer. 

August 20, 2020

In our exclusive interview, Dr. Levy discusses the challenges of targeting KRAS and highlighted some of the investigational agents directed toward KRAS G12C mutations that have emerged in the NSCLC pipeline.

May 18, 2020

Treatment approaches are being refined by the primary location of gastroesophageal junction tumors.

May 18, 2020

Treatment approaches are being refined by the primary location of gastroesophageal junction tumors.

May 15, 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

May 14, 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

May 04, 2020

Nivolumab, when administered approximately 4 weeks prior to surgery in patients with Merkel cell carcinoma, was found to be tolerable and to induce pathological complete responses and radiographic tumor regressions.

May 02, 2020

Jean Wright, MD, discusses proton versus photon radiotherapy in breast cancer.

April 28, 2020

Amanda Nickles Fader, MD, discusses the rationale for a phase II study and explains how the findings could open the door to other treatment options for women with uterine serous carcinoma.

April 24, 2020

Emmanuel S. Antonarakis, MBBCh, discusses the efficacy of radium-223 plus sipuleucel-T in patients with bone-metastatic castration-resistant prostate cancer and the next steps for research for this combination.

April 24, 2020

Amanda Nickles Fader, MD, discusses the utility of trastuzumab plus chemotherapy in HER2-positive uterine serous carcinoma.

April 15, 2020

Amanda Nickles Fader, MD, discusses the rationale for utilizing HER2/neu as a target in uterine serous carcinoma.